| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 07/27/2005 | CN1646143A Combination of a beta-2 adrenoceptor agonists and an aminosugars and their use for the treatment immunomodulatory disorders |
| 07/27/2005 | CN1646141A Modified nucleosides for treatment of viral infections and abnormal cellular proliferation |
| 07/27/2005 | CN1646139A Use of pyrimidine nucleotides for the treatment of affections of the peripheral nervous system |
| 07/27/2005 | CN1646138A Novel therapeutical use of agonist ligands specific to G2A receptor |
| 07/27/2005 | CN1646131A Novel compounds |
| 07/27/2005 | CN1646129A Dosing regimen for gemcitabine HCV therapy |
| 07/27/2005 | CN1646124A Use of materials having zinc ionophoric behavior |
| 07/27/2005 | CN1646114A Personal care compositions comprising a zinc containing material in an aqueous surfactant composition |
| 07/27/2005 | CN1646104A Dry granulated formulations of azithromycin |
| 07/27/2005 | CN1646100A Dispersed solid-containing complex carbohydrate |
| 07/27/2005 | CN1646093A Method and composition for treatment of inflammation and AIDS-associated neurological disorders |
| 07/27/2005 | CN1646026A Cheese capable of disinfecting helicobacter pylori |
| 07/27/2005 | CN1644708A Mycobacterium tuberculosis superoxide dismutase |
| 07/27/2005 | CN1644692A Hippocampus protease inhibitor gene and its use |
| 07/27/2005 | CN1644586A Oxydiertes thymosin beta 4 |
| 07/27/2005 | CN1644583A Cephe alkene onium salt compound and its preparation and use in preparation of cefepime |
| 07/27/2005 | CN1644214A YG and YGG used as maintenance and improvement of immunoreaction |
| 07/27/2005 | CN1644213A Chinese medicinal preparation for treating liver cancer, hepatitis B cirrhosis and preventing liver fibrillation and preparation thereof |
| 07/27/2005 | CN1644210A Soft capsule for treating cough and preparation thereof |
| 07/27/2005 | CN1644207A Chinese medicinal preparation for treating skin disease |
| 07/27/2005 | CN1644206A Medicine for treating tinea containing biological alkaline salt and preparation thereof |
| 07/27/2005 | CN1644202A Cucurbitacin liquid composition and preparation thereof |
| 07/27/2005 | CN1644200A Ganciclovir as ophthalmic medicine and its preparation |
| 07/27/2005 | CN1644199A Use of ampeloptin in preparation of antivirus medicines |
| 07/27/2005 | CN1212400C Method for obtaining transgenic rape chloroplast plant for producing foot-and-mouth disease vaccine |
| 07/27/2005 | CN1212399C Method for obtaining transgenic mountain lettuce chloroplast plant for producing foot-and-mouth disease vaccine |
| 07/27/2005 | CN1212335C ICE hibiting peptides |
| 07/27/2005 | CN1212330C Medicinal complex dibaicalin zinc and its preparation method |
| 07/27/2005 | CN1212329C Matching substance with flavone contained in erigeron breviscapus as ligand and its usage |
| 07/27/2005 | CN1212324C Method for preparing crystalline cefathiamidine and its usage |
| 07/27/2005 | CN1212317C Novel ester or amide derivatives |
| 07/27/2005 | CN1212315C Coffee acyl naphthalene sulfonamides compound and method for preparing the same and anti-HIV conformity enzyme action |
| 07/27/2005 | CN1212153C Immunologic adjuvant origniated from plants, and its preparing method and use |
| 07/27/2005 | CN1212151C Capsule of cordyceps |
| 07/27/2005 | CN1212150C Medicine for treating virus hepatitis and its preparing process |
| 07/27/2005 | CN1212145C Use of extract of rhizome of Chinese paris |
| 07/27/2005 | CN1212134C Commpound Chinese medicine preparation for treating urinary system infection and prostatitis and its preparing process |
| 07/27/2005 | CN1212121C Product of ginsenoside for curing hepatitis |
| 07/27/2005 | CN1212118C Preparation method of powder-injections of cyclonorfloxacin and its salts and their preparation products |
| 07/27/2005 | CN1212116C Sophorcarpidine alkaloid and decongestant compound medicine and its preparation |
| 07/26/2005 | US6921826 Thioether substituted imidazoquinolines |
| 07/26/2005 | US6921809 Immunoglobulin conjugate comprising amino acid sequences from dihydrolipoamide dehydrogenase (P64K) for use as tool in immunodetection of heterologous protein expression; vaccine development |
| 07/26/2005 | US6921763 Protein kinase inhibitors |
| 07/26/2005 | US6921762 Substituted indolizine-like compounds and methods of use |
| 07/26/2005 | US6921759 For therapy, prophylaxis or delaying the onset of AIDS and infection by HIV |
| 07/26/2005 | US6921543 Administering immunogenically effective amount of immunogen and an immunomodulatory effective amount of a lipid extract of Perna canaliculus or Mytilus edulis for modulating the immune response to an immunogen in a human or animal patient |
| 07/26/2005 | US6921537 Extracting with a polyoxyethylene detergent to deplete inner membranes, extracting remaining outer membranes with zwitterionic betaine dertergent to separate lipooligosaccharides from insoluble factions used for vaccines |
| 07/26/2005 | US6921536 Lawsonia intracellularis vaccine |
| 07/26/2005 | US6921534 Hepatitis B virus treatment |
| 07/26/2005 | CA2315481C Selective inhibition of aggrecanase in osteoarthritis treatment |
| 07/26/2005 | CA2294562C Hepatitis c inhibitor peptide analogues |
| 07/26/2005 | CA2269115C Monovalent antibody fragments |
| 07/26/2005 | CA2089552C Inactivated mycoplasma hyopneumoniae bacterin and method of use thereof |
| 07/21/2005 | WO2005066193A1 Levulose glucoselipid a analogue |
| 07/21/2005 | WO2005066181A1 Process for the preparation of 1,3-dioxolo [4,5-c] piperidin-7-ols and related compounds |
| 07/21/2005 | WO2005065671A1 Preventive for the onset of liver cancer comprising quinone compound as the active ingredient |
| 07/21/2005 | WO2005065063A2 Use of the mushroom agaricus blazei murill for the production of medicaments suitable for treating infections and allergies |
| 07/21/2005 | WO2005065015A2 Neutralizing antibodies and methods of use thereof |
| 07/21/2005 | WO2005037866A3 Igg3 anti rhesus-d in the line yb2/0 having a high phagocytosis activity |
| 07/21/2005 | WO2004113365A3 Hepatitis c serine protease tri-peptide inhibitors |
| 07/21/2005 | US20050159589 Process for the purification and/or isolation of biologically active granulocyte colony stimulating factor |
| 07/21/2005 | US20050159585 Forming acyl azide function on acid group of amino acid derivative, then transforming to isocyanate |
| 07/21/2005 | US20050159584 O-succinimidyl-2-[(9H-fluoren-9-ylmethoxy)carbonylamino]-ethylcarbamate's used as monomers active in the synthesis of di- and tri-substituted ureas and urea oligomers |
| 07/21/2005 | US20050159477 Prepared by suspending pseudomonic acid in water and gradually adding calcium hydroxide to pH of 7.8-8.5, filtering, and lyophilizing frozen solution of calcium pseudomonate in water; stable topical pharmaceutical preparations |
| 07/21/2005 | US20050159463 5-methoxy-3-(2-(2-furamido) ethyl)indole; related to melatonin, but pharmacologicaly and pharmacokineticy different; longer duration, selective localization and greater efficacy |
| 07/21/2005 | US20050159451 NMDA (N-methyl-D-aspartate) receptors; eg 6-(4-benzylpiperidin-1-carbonyl)-1,5-dihydro-oxazolo[4,5-f]indole-2-one |
| 07/21/2005 | US20050159412 hydroxamic acid and N-formyl hydroxylamine compounds which inhibit the activity of the bacterial enzyme known as peptide deformylase |
| 07/21/2005 | US20050159411 Bactericides for infrections in man |
| 07/21/2005 | US20050159401 Treating atheroma, tumors and other neoplastic tissue; treating atherosclerotic inflammation; forming a complexes with a reducing agent, penetrate and accumulate more rapidly in tumor cells, plaque, increase drug in intracellular concentration; increase photosensitivity |
| 07/21/2005 | US20050159392 Phosphoramidate linkages; retroviral or hepadnaviral therapy; tissue targeted therapy; HIV/aquired immunodeficiency syndrome; antitumor agents; improved bioavailability |
| 07/21/2005 | US20050159386 Antitumoral composition based on immunogenic polypeptide with modified cell location |
| 07/21/2005 | US20050159371 Process for producing erythromycin a derivative |
| 07/21/2005 | US20050159365 Hepatits c virus inhibitor comprising alpha-glycosylceramide as the active ingredient |
| 07/21/2005 | US20050159345 Such as encephalitis and hepatitis |
| 07/21/2005 | US20050159332 Ntb-a,a a surface molecule involved in natural killer cellss activity |
| 07/21/2005 | US20050158785 Non-peptide compounds 2-(5(6)-nitro-2-benzimidazoyl)-5-(4-nitrophenyl)furan; for use in bioassay, fluorescent quantitative analysis; control of gene expression, treatment/prevention of cancer |
| 07/21/2005 | US20050158778 Transcription factor for use in generating immoglobulin for prevention and treatment of fungal infection |
| 07/21/2005 | US20050158724 Methods, of identifying compounds that modulate a dna repair pathway and/or retroviral infectivity, the compounds, and uses thereof |
| 07/21/2005 | US20050158714 Polypeptide nucleic sequences exported from mycobacteria, vectors comprising same and uses for diagnosing and preventing tuberculosis |
| 07/21/2005 | US20050158713 Fitness assay and associated methods |
| 07/21/2005 | US20050158709 Determining effect of human serum protein on viricidal agents; bioassay; enzyme inhibitors; plasma protein binding and drug efficacy; drug screening and pharmacokinetics |
| 07/21/2005 | US20050158703 Cytocapacity test for the prediction of the hematopoietic recovery, neutropenic fever, and antimicrobial treatment following high-dose cytotoxic chemotherapy |
| 07/21/2005 | US20050158345 ABC (ATP-binding cassette) transporters; polynucleotides, expression vectors, transformed host cells and antibodies; use in vaccination |
| 07/21/2005 | US20050158341 Tat and Nef to promote localized accumulation of CD4+ cells, and a compound that stimulates the differentiation of CD4+ ThO cells into either Th1 cells or Th2 cells such as interleukin-4 or an antibody that is capable of binding interferon gamma; treating HIV infections |
| 07/21/2005 | US20050158334 Vaccines comprising aluminium adjuvants and histidine |
| 07/21/2005 | US20050158317 Novel proteins with il-6 inhibiting activity |
| 07/21/2005 | US20050158278 Means and methods for the production of adenovirus vectors |
| 07/21/2005 | US20050158277 Method to genetate non virulent microorganisms from pathogenic ones through permanent genetic modification of their biological membrane for vaccine production |
| 07/21/2005 | US20050158276 Bordetella pertussis antigen consisting lipopolysaccharide, pertusis toxin, filamentous hemagglutinin, pertactin or abosrbed to alum; interleukin-12 ; enhances cell-mediated immunity in a host |
| 07/21/2005 | US20050158263 Pyrithione biocides enhanced by zinc metal ions and organic amines |
| 07/21/2005 | US20050158255 Use of benzotriazole UV absorbers |
| 07/21/2005 | US20050158244 Cell population from staining a neoplastic cell population with a first marker, staining a dendritic cell population with a second marker, fusing the cells to obtain hybrid cell population stained with both markers; purifying |
| 07/21/2005 | CA2552222A1 Antiviral compositions which inhibit paramyxovirus infection |
| 07/21/2005 | CA2552188A1 Polypeptides and immunogenic conjugates capable of inducing antibodies against pathogens, and uses thereof |
| 07/21/2005 | CA2552101A1 Piperazine, [1,4]diazepane, [1,4]diazocane, and [1,5]diazocane fused imidazo ring compounds |
| 07/21/2005 | CA2550709A1 Preventive for the onset of liver cancer comprising quinone compound as the active ingredient |
| 07/21/2005 | CA2548990A1 Toll-like receptor 4 (tlr4)-neutralizing antibodies |
| 07/21/2005 | CA2546039A1 Novel polymorphs of racemic, dextrorotatory, and levorotatory enantiomers of 1-cyclopropyl-6-fluoro-8-methoxy-7-(4-amino-3,3-dimethylpiperidin-1-yl)-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid hydrochloride and mesylate salts |
| 07/20/2005 | EP1555270A1 HCV NS3 proteins and nucleic acids |
| 07/20/2005 | EP1555267A1 2,3-DIHYDRO-6-NITROIMIDAZO 2,1-b OXAZOLES |